First Time Loading...

Histogen Inc
NASDAQ:HSTO

Watchlist Manager
Histogen Inc Logo
Histogen Inc
NASDAQ:HSTO
Watchlist
Price: 0.35 USD
Updated: Apr 24, 2024

Intrinsic Value

HSTO doesn't have a meaningful market cap.
HSTO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Histogen, Inc. engages in the development of potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. [ Read More ]

The intrinsic value of one HSTO stock under the Base Case scenario is 0.11 USD. Compared to the current market price of 0.35 USD, Histogen Inc is Overvalued by 70%.

Key Points:
HSTO Intrinsic Value
Base Case
0.11 USD
Overvaluation 70%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Histogen Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling HSTO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Histogen Inc

Provide an overview of the primary business activities
of Histogen Inc.

What unique competitive advantages
does Histogen Inc hold over its rivals?

What risks and challenges
does Histogen Inc face in the near future?

Has there been any significant insider trading activity
in Histogen Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Histogen Inc.

Provide P/S
for Histogen Inc.

Provide P/E
for Histogen Inc.

Provide P/OCF
for Histogen Inc.

Provide P/FCFE
for Histogen Inc.

Provide P/B
for Histogen Inc.

Provide EV/S
for Histogen Inc.

Provide EV/GP
for Histogen Inc.

Provide EV/EBITDA
for Histogen Inc.

Provide EV/EBIT
for Histogen Inc.

Provide EV/OCF
for Histogen Inc.

Provide EV/FCFF
for Histogen Inc.

Provide EV/IC
for Histogen Inc.

Show me price targets
for Histogen Inc made by professional analysts.

What are the Revenue projections
for Histogen Inc?

How accurate were the past Revenue estimates
for Histogen Inc?

What are the Net Income projections
for Histogen Inc?

How accurate were the past Net Income estimates
for Histogen Inc?

What are the EPS projections
for Histogen Inc?

How accurate were the past EPS estimates
for Histogen Inc?

What are the EBIT projections
for Histogen Inc?

How accurate were the past EBIT estimates
for Histogen Inc?

Compare the revenue forecasts
for Histogen Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Histogen Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Histogen Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Histogen Inc compared to its peers.

Compare the P/E ratios
of Histogen Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Histogen Inc with its peers.

Analyze the financial leverage
of Histogen Inc compared to its main competitors.

Show all profitability ratios
for Histogen Inc.

Provide ROE
for Histogen Inc.

Provide ROA
for Histogen Inc.

Provide ROIC
for Histogen Inc.

Provide ROCE
for Histogen Inc.

Provide Gross Margin
for Histogen Inc.

Provide Operating Margin
for Histogen Inc.

Provide Net Margin
for Histogen Inc.

Provide FCF Margin
for Histogen Inc.

Show all solvency ratios
for Histogen Inc.

Provide D/E Ratio
for Histogen Inc.

Provide D/A Ratio
for Histogen Inc.

Provide Interest Coverage Ratio
for Histogen Inc.

Provide Altman Z-Score Ratio
for Histogen Inc.

Provide Quick Ratio
for Histogen Inc.

Provide Current Ratio
for Histogen Inc.

Provide Cash Ratio
for Histogen Inc.

What is the historical Revenue growth
over the last 5 years for Histogen Inc?

What is the historical Net Income growth
over the last 5 years for Histogen Inc?

What is the current Free Cash Flow
of Histogen Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Histogen Inc.

Financials

Balance Sheet Decomposition
Histogen Inc

Current Assets 5.5m
Cash & Short-Term Investments 4.6m
Other Current Assets 890k
Non-Current Assets 360k
Other Non-Current Assets 360k
Current Liabilities 1.4m
Accounts Payable 390k
Accrued Liabilities 940k
Other Current Liabilities 20k
Non-Current Liabilities -970k
Other Non-Current Liabilities -970k
Efficiency

Earnings Waterfall
Histogen Inc

Revenue
30k USD
Operating Expenses
-12.1m USD
Operating Income
-12.1m USD
Other Expenses
-310k USD
Net Income
-12.4m USD

Free Cash Flow Analysis
Histogen Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

HSTO Profitability Score
Profitability Due Diligence

Histogen Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

14/100
Profitability
Score

Histogen Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

HSTO Solvency Score
Solvency Due Diligence

Histogen Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Histogen Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HSTO Price Targets Summary
Histogen Inc

Wall Street analysts forecast HSTO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HSTO is 2 USD .

Lowest
Price Target
Not Available
Average
Price Target
2 USD
471% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

HSTO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

HSTO Price
Histogen Inc

1M 1M
-10%
6M 6M
+6%
1Y 1Y
-63%
3Y 3Y
-98%
5Y 5Y
-100%
10Y 10Y
-100%
Annual Price Range
0.35
52w Low
0.15
52w High
0.95
Price Metrics
Average Annual Return -68.79%
Standard Deviation of Annual Returns 17.73%
Max Drawdown -100%
Shares Statistics
Market Capitalization 1.5m USD
Shares Outstanding 4 271 760
Percentage of Shares Shorted 1.62%

HSTO Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Histogen Inc Logo
Histogen Inc

Country

United States of America

Industry

Biotechnology

Market Cap

1.5m USD

Dividend Yield

0%

Description

Histogen, Inc. engages in the development of potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. The company is headquartered in San Diego, California and currently employs 22 full-time employees. The company went IPO on 2013-07-25. The firm is focused on developing its hypoxia-generated growth factor technology platform and stem cell-free biologic products as restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. The firm's product pipelines include CCM Cosmetics, HST 003, HST 004, and Emricasan. In addition, within its small molecule pipeline, its product candidates also include CTS-2090 and CTS-2096. Its HST-003 is a human extracellular matrix (hECM), which is focused on regenerating hyaline cartilage for the treatment of articular cartilage defects in the knee, with a malleable scaffold that stimulates the body’s own stem cells. HST 004 is a cell conditioned medium (CCM) solution, which is used for treatment of spinal disc repair. Emricasan is an orally active pan-caspase inhibitor being developed for the treatment of COVID-19.

Contact

CALIFORNIA
San Diego
10655 Sorrento Valley Road, Suite 200
+18585263100.0
https://histogen.com/

IPO

2013-07-25

Employees

22

Officers

President, CEO, CFO, COO, Chief Compliance Officer & Corporate Secretary
Ms. Susan A. Knudson

See Also

Discover More
What is the Intrinsic Value of one HSTO stock?

The intrinsic value of one HSTO stock under the Base Case scenario is 0.11 USD.

Is HSTO stock undervalued or overvalued?

Compared to the current market price of 0.35 USD, Histogen Inc is Overvalued by 70%.